A detailed history of Clarius Group, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 16,080 shares of PRME stock, worth $51,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,080
Previous 16,080 -0.0%
Holding current value
$51,456
Previous $82,000 24.39%
% of portfolio
0.0%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

BUY
$15.2 - $21.12 $244,416 - $339,609
16,080 New
16,080 $299,000

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $306M
More about PRME
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.